Concepedia
Statistics
Publications
4
Citations
79
H-Index
Active since
2020
Affiliations
University of Chinese Academy of Sciences(Current)
Shanghai Institute of Materia Medica
Chinese Academy of Sciences
Shanghai Jiao Tong University
Mengdi Dai is an author at University of Chinese Academy of Sciences specializing in drug discovery, medicinal chemistry, and pharmacy.
Publications per year
2020–2023
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
Xiaowei Wu, Mengdi Dai, Rongrong Cui et al. · Acta Pharmaceutica Sinica B · 2020 · 30 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors
Cheng-Hu Xie, Bo Liu, Zilan Song et al. · Journal of Medicinal Chemistry · 2023 · 27 citations · Full text
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer
Ji Zhou, Xu‐Chao Zhang, Shan Xue et al. · Signal Transduction and Targeted Therapy · 2023 · 12 citations · Full text
Medicine, Cancer Biology, Oncology +17
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo
Mengdi Dai, Yue-liang Wang, Jun Fan et al. · Acta Pharmacologica Sinica · 2020 · 10 citations · Full text
Medicine, Oncology, Pharmacology +7
1–4 of 4